Triangle Business Journal -- Maybe a year was enough. After fighting for more than a year to change the way biopharmaceutical company Icagen does business, one of the company’s largest investors has started selling its stock in the company.
Triangle Business Journal -- Maybe a year was enough. After fighting for more than a year to change the way biopharmaceutical company Icagen does business, one of the company’s largest investors has started selling its stock in the company.
